| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $1,563,886 | +39,946 | +29% | $39.15 | 177,131 | 16 Feb 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $6,391,400 | -39,946 | -23% | $160.00 | 137,185 | 16 Feb 2023 | Direct | F1, F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -39,946 | -100% | $0.000000* | 0 | 16 Feb 2023 | Common Stock | 39,946 | $39.15 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $160.00 to $160.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all the options were fully vested on 8/25/19. |